Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:35 pm Purchase | 2025-12-31 | 13G | Forte Biosciences, Inc. FBRX | JANUS HENDERSON GROUP PLC JHG | 1,425,785 11.400% | 768,276 (+116.85%) | Filing History |
| 2026-01-29 7:57 pm Sale | 2026-01-22 | 13G | Forte Biosciences, Inc. FBRX | Affinity Asset Advisors LLC | 834,964 6.700% | -27,436 (-3.18%) | Filing History |
| 2026-01-20 4:51 pm Purchase | 2026-01-12 | 13G | Forte Biosciences, Inc. FBRX | Point72 Asset Management, L.P. | 792,976 6.300% | 792,976 (New Position) | Filing History |
| 2026-01-09 6:19 pm Sale | 2026-01-08 | 13G | Forte Biosciences, Inc. FBRX | Oliveira Steven Michael | 300,100 2.400% | -132,176 (-30.58%) | Filing History |
| 2025-12-23 5:15 pm Purchase | 2025-12-17 | 13G | Forte Biosciences, Inc. FBRX | Affinity Asset Advisors LLC | 862,400 6.900% | 862,400 (New Position) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | Forte Biosciences, Inc. FBRX | BIOTECHNOLOGY VALUE FUND L P | 65,350 0.500% | -578,272 (-89.85%) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 1,634,267 13.100% | 15,618 (+0.96%) | Filing History |
| 2025-10-07 11:08 am Purchase | 2025-09-30 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,635,380 13.150% | 156,733 (+10.60%) | Filing History |
| 2025-09-05 09:38 am Purchase | 2025-08-31 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,478,647 11.890% | 406,414 (+37.90%) | Filing History |
| 2025-08-14 4:27 pm Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 1,618,649 13.300% | 708,040 (+77.75%) | Filing History |
| 2025-08-14 4:20 pm Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | Ikarian Capital, LLC | 617,667 4.990% | 8,442 (+1.39%) | Filing History |
| 2025-08-14 11:46 am Unchanged | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | JANUS HENDERSON GROUP PLC JHG | 657,509 9.900% | 0 (Unchanged) | Filing History |
| 2025-08-07 2:43 pm Sale | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | BOOTHBAY FUND MANAGEMENT LLC | 53,791 0.800% | -34,994 (-39.41%) | Filing History |
| 2025-08-04 6:21 pm Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,268,086 9.990% | 627,316 (+97.90%) | Filing History |
| 2025-07-08 07:50 am Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,072,233 8.780% | 1,072,233 (New Position) | Filing History |
| 2025-05-15 7:43 pm Sale | 2025-03-31 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 910,609 14.200% | -223,335 (-19.70%) | Filing History |
| 2025-05-14 12:49 pm Sale | 2025-03-31 | 13G | Forte Biosciences, Inc. FBRX | JANUS HENDERSON GROUP PLC JHG | 657,509 9.900% | -33,234 (-4.81%) | Filing History |
| 2025-02-14 5:18 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 1,133,944 17.700% | 175,019 (+18.25%) | Filing History |
| 2025-02-14 4:33 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 640,770 9.990% | 640,770 (New Position) | Filing History |
| 2025-02-14 4:22 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | ORBIMED ADVISORS LLC | 510,000 8.000% | 510,000 (New Position) | Filing History |